The epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome: The Kaiser Permanente polycystic ovary syndrome (KP-PCOS) study

被引：0
|
作者：
Lo, Joan C.
Feigenbaum, Seth L.
Yang, Jingrong
Pressman, Alice R.
Selby, Joe V.
Go, Alan S.
机构：
[1] Univ Calif San Francisco, Dept Med, Div Endocrinol & Metab, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
来源：
JOURNAL OF WOMENS HEALTH | 2006年 / 15卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：679 / 679
页数：1
相关论文
共 50 条
  • [41] A guide to understanding polycystic ovary syndrome (PCOS)
    Duncan, W. Colin
    JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2014, 40 (03): : 217 - 225
  • [42] Microbiome and metabolism in polycystic ovary syndrome (PCOS)
    Heizmann, Wolfgang R.
    Keck, Christoph
    GYNAKOLOGE, 2021, 54 (10): : 732 - 740
  • [43] RISK FACTORS FOR INCIDENT POLYCYSTIC OVARY SYNDROME (PCOS) DIAGNOSIS
    Christ, Jacob
    Yu, Onchee
    Schulze-Rath, Renate
    Covey, Jennifer
    Holden, Erika
    Hilpert, Jan
    Micks, Elizabeth
    Reed, Susan D.
    FERTILITY AND STERILITY, 2022, 118 (04) : E188 - E188
  • [44] Role of kisspeptin in polycystic ovary syndrome (PCOS)
    Ozay, Ozlen Emekci
    Ozay, Ali Cenk
    Acar, Berrin
    Cagliyan, Erkan
    Secil, Mustafa
    Kume, Tuncay
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (09) : 718 - 722
  • [45] Reproductive impact of polycystic ovary syndrome (PCOS)
    Dominguez, Gonzalez R.
    GIORNALE ITALIANO DI OSTETRICIA E GINECOLOGIA, 2016, 38 (01): : 79 - 82
  • [46] Prolactin secretion in polycystic ovary syndrome (PCOS)
    Szosland, Konrad
    Pawlowicz, Pawel
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2015, 36 (01) : 53 - 58
  • [47] Are polycystic ovaries associated with cardiovascular disease risk as polycystic ovary syndrome?
    Engin-Uestuen, Yaprak
    Ustun, Yusuf
    Meydanli, M. Mutlu
    Kafkasli, Ayse
    Yetkin, Guelay
    GYNECOLOGICAL ENDOCRINOLOGY, 2006, 22 (06) : 324 - 328
  • [48] Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
    Wild, Robert A.
    Carmina, Enrico
    Diamanti-Kandarakis, Evanthia
    Dokras, Anuja
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Lobo, Rogerio
    Norman, Robert J.
    Talbott, Evelyn
    Dumesic, Daniel A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05): : 2038 - 2049
  • [49] The cardiometabolic risk profile of middle-aged women with polycystic ovary syndrome (PCOS)
    Meun, C.
    Gunning, M.
    Louwers, Y.
    Peters, H.
    Roos-Hesselink, J.
    van Lennep, J. Roeters
    Leonel, O. Ochoa Rueda
    Ikram, A.
    Appelman, Y.
    Lambalk, N.
    Boersma, E.
    Kavousi, M.
    Fauser, B.
    Laven, J.
    HUMAN REPRODUCTION, 2019, 34 : 454 - 454
  • [50] Psychopathological profile in polycystic ovary syndrome (PCOS): an integrated interdisciplinary approach
    Lepadatu, C.
    Leone, D.
    Garzia, E.
    Galiano, V.
    Borghi, L.
    Vegni, E.
    Sulpizio, P.
    HUMAN REPRODUCTION, 2014, 29 : 348 - 349
12345